SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (298)1/9/2003 2:37:58 AM
From: Londo  Read Replies (1) | Respond to of 897
 
First person I thought of when I saw this PR was you, Tuck.

About VXGN: That PR is their first ticket on the way down to 3 bucks a share.

Implied volatility on their options is 150%, and who in their right mind would want to pay the $4.00 ask on the February 17.50 put options when the common is trading at $17.95? Just insane. It just seems to me now that the best way to play this one is be the liquidity provider (i.e. sit on the ask) on the February/May 20, 22.5, 25 call options, and just get a delta equivalent to the number of shares that you otherwise wanted to short. And also pray that the specialists are nice enough to give you the order flow.



To: tuck who wrote (298)3/21/2003 11:21:11 AM
From: tuck  Respond to of 897
 
Methinks AGEN is running into resistance here, and that this rally will stall in the next few days or sooner. The desert is one thing, Baghdad another.

Short full position: 2200 shares at $9.10, stop at $9.50.

Watching CTIC, CHIR, AMGN, ALKS.

Cheers, Tuck